79399431 - LIVACHAR

Information

  • Trademark
  • 79399431
  • Serial Number
    79399431
  • Registration Number
    7617326
  • Filing Date
    June 03, 2024
    7 months ago
  • Registration Date
    December 24, 2024
    25 days ago
  • Transaction Date
    January 10, 2025
    8 days ago
  • Status Date
    December 24, 2024
    25 days ago
  • Published for Opposition Date
    November 05, 2024
    2 months ago
  • Location Date
    December 23, 2024
    26 days ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    SMITH, CAROLINE
  • Owners
Mark Drawing Code
4
Mark Identification
LIVACHAR
Case File Statements
  • GS0051: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, pharmaceutical preparations for treatment of fatty liver and steatohepatitis, pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders, pharmaceutical preparations for the treatment of digestive system disease, pharmaceutical preparations for the treatment of primary biliary cirrhosis, pharmaceutical preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, pharmaceutical preparations for the treatment of liver disease, pharmaceutical preparations for the treatment of metabolic disease, pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system, analgesics; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; veterinary preparations, namely, veterinary preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, veterinary preparations for treatment of fatty liver and steatohepatitis, veterinary preparations for the treatment of cardiovascular disorders and metabolic disorders, veterinary preparations for the treatment of digestive system disease, veterinary preparations for the treatment of primary biliary cirrhosis, veterinary preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, veterinary preparations for the treatment of liver disease, veterinary preparations for the treatment of metabolic disease, veterinary preparations for the prevention and treatment of disorders of the metabolic system, analgesics; veterinary pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; veterinary pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; sanitary preparations for medical use; anti-inflammatory agents, namely, topical preparations in the form of gels and salves, adhesive skin patches, liquid formulations, cream and sprays, all for relieving pain.
Case File Event Statements
  • 7/5/2024 - 6 months ago
    1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Type: SDRC
  • 7/8/2024 - 6 months ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 7/9/2024 - 6 months ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/9/2024 - 6 months ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 9/16/2024 - 4 months ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/16/2024 - 3 months ago
    7 - NOTICE OF PUBLICATION Type: NPUB
  • 11/5/2024 - 2 months ago
    8 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/24/2024 - 3 months ago
    6 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/24/2024 - 25 days ago
    9 - REGISTERED-PRINCIPAL REGISTER Type: R.PR